WHO ICTRP trial
A randomized, double-blind, parallel controlled, multicentre exploratory…
ChiCTR2400084434 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2400084434 |
|---|---|
| Public title | A randomized, double-blind, parallel controlled, multicentre exploratory clinical trial on the efficacy and safety of Nvzhen Granule in treating chronic insomnia (liver-kidney Yin deficiency, heart-liver fire hyperactivity syndrome) |
| Scientific title | A randomized, double-blind, parallel controlled, multicentre exploratory clinical trial on the efficacy and safety of Nvzhen Granule in treating chronic insomnia (liver-kidney Yin deficiency, heart-liver fire hyperactivity syndrome) |
| Primary sponsor | Dongzhimen Hospital, Beijing University of Chinese Medicine |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | Chronic insomnia (liver and kidney Yin deficiency, heart-liver fire-flourishing syndrome) |
| Interventions | Test group:Nvzhen Granule orally, 6g/ time, 3 times/day, once in the morning, middle and evening;Control group:Nvzhen Granule simulation agent orally, 6g/ time, 3 times/day, once in the morning, middle and evening |
| Registration date | May 16, 2024 |
| Target size | Test group:96;Control group:96 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: